International meetings - oral presentations

  1. Indocyanine green autofluorescence in adrenal surgery – can the yield of lymph node dissection be improved. ? B Puttergill, Khan S, Mihai R. European Society of Endocrine Surgeons meeting (Cordoba, May 2019)

  2. Survey of UK trainees about experience in thyroid surgery. Khan S, Mihai R.  European Society of Endocrine Surgeons meeting (Cordoba, May 2019)

  3. MacGregor TP, Chetty R, Sharma RA, Mihai R.  Development of XPF protein levels as a predictive biomarker in patients with adrenocortical cancer. European Society of Endocrine Surgeons  meeting (Cardiff, May 2014).  Langenbecks Arch Surg399:5382.

  4.  Mihai R, Cutter D, Pezella F, Ramasamy K. Isolated thyroid plasmacytoma – a very rare disease. European Society of Endocrine Surgeons  meeting (Berlin, May 2013)

  5. Crag WL, Harrison BJ, Mihai R, Scott-Coombes D, Krukowski ZH.  National outcomes for thyroid cancer in the United Kingdom. European Society of Endocrine Surgeons  meeting (Berlin, May 2013).

  6. Parameswaran R, Sadler G, Mihai R. Central compartment lymph node dissection for papillary thyroid cancer – impact of lymph node yield on local recurrence.  European Society of Endocrine Surgeons  meeting, Goteborg, May 2012

  7. Mihai R, Iacobone M, Kraimps JL, Soriano A, Villar J, Barczinski M, Frilling A, Sadler G, Niederle B, Harrison B, Dralle H, Carnaille B.  Adrenocortical cancer invading the inferior vena cava – a ESES survey. European Society of Endocrine Surgeon, Lyon, May 2011

  8. Juszczak A, Halliday D, Mihai R, Ali A.  A large adrenal tumour as a phenotypic manifestation of the Birt-Hogg-Dube syndrome. European Society of Endocrinology meeting, Rotterdam, May 2011

  9. Gopinath P, Sadler G, Mihai R. 2010 Persistent improvement in quality of life more than 12 months after parathyroidectomy

  10. Mihai R. The rationale for selective parathyroidectomy. European Society of Endocrine Surgeons  meeting, Lundt, March 2009

  11. Mihai R. Sestamibi scanning for primary hyperparathyroidism. European Society of Endocrine Surgeons  meeting, Lundt, March 2009

  12.  Stechman M, Gleeson F, Sadler G, Mihai R.  Positive preoperative localisation scanning does not affect the likelihood of surgical cure in patients with primary hyperparathyroidism. European Society of Endocrine Surgeons  meeting, Lundt, March 2009

  13. Mihai R, Stechman M, Gleeson F, Sadler G. Cost-effectiveness of scan-directed parathyroidectomy.  European Society of Endocrine Surgeons  meeting, Barcelona, May 2008

  14. Mihai R, Gleeson F, Sadler G.  No need for routine I123-MBG scanning in patients with sporadic phaeochromocytomas.  European Society of Endocrine Surgeons  meeting, Barcelona, May 2008

  15. Mihai R, D Jeevan, G Sadler. Pasieka’s parathyroid symptoms scores correlate with SF-36 scores in patients operated for primary hyperparathyroidism. International Assoc of Endocrine Surgeons, Montreal, Canada, August 2007

  16. Mihai R, Sadler G.  Treatment of hyperparathyroidism in the era of preoperative imaging.  Balkanic Congress of Endocrinology. Bucharest, Nov 2005

  17. Mihai R.  The calcium sensing receptor – from calcium homeostasis to understanding selection of bone metastases. Balkanic Congress of Endocrinology. Bucharest, Nov 2005

  18. Mihai R, Gleeson F, Buley I, Roskell D, Sadler G.  Histological analysis of parathyroid tumours suggests a reason why negative imaging studies for primary hyperparathyroidism are unavoidable: results of sestamibi and high-resolution ultrasound scanning in 150 patients.  International Assoc of Endocrine Surgeons, Durban, South Africa, August 2005